Firefly Neuroscience (AIFF) EBT (2010 - 2026)

Firefly Neuroscience has reported EBT for 16 years, with the latest figure at -$2.0 million in Q2 2026.

• On a quarterly basis, EBT fell 8.47% year-over-year to -$2.0 million in Q2 2026; TTM through Jun 2026 was -$9.1 million, a 61.77% increase from a year earlier, with the FY2025 full-year figure at -$19.9 million, down 90.07% from the prior year.
• EBT was -$2.0 million for Q2 2026 at Firefly Neuroscience, up from -$2.0 million in the prior quarter.
• The five-year high for EBT was $456438.0 in Q2 2023, with the low at -$12.9 million in Q1 2025.
• Average EBT over 5 years is -$2.5 million, with a median of -$1.7 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: EBT slumped 3851.17% in 2022, then jumped 128.19% in 2023.
• Over 5 years, EBT stood at -$1.0 million in 2022, then slipped by 4.32% to -$1.1 million in 2023, then sank by 520.35% to -$6.7 million in 2024, then soared by 62.86% to -$2.5 million in 2025, then climbed by 19.97% to -$2.0 million in 2026.
• The last three EBT figures came in at -$2.0 million (Q2 2026), -$2.0 million (Q1 2026), and -$2.5 million (Q4 2025), per Business Quant data.